==== Front World J Surg Oncol World J Surg Oncol World Journal of Surgical Oncology 1477-7819 BioMed Central London 2092 10.1186/s12957-020-02092-3 Research Perioperative risk factors of psychological distress in patients undergoing treatment for esophageal cancer http://orcid.org/0000-0002-5073-5596Ohkura Yu yu.ohkura107@gmail.com 123 Shindoh Junichi jshindoh@gmail.com 23 Ichikura Kanako ichikura.k@gmail.com 4 Udagawa Harushi udagawah@toranomon.gr.jp 23 Ueno Masaki ueno.m@nifty.com 23 Matsushima Eisuke emlppm@gmail.com 1 1 grid.265073.50000 0001 1014 9130Section Division of Liaison Psychiatry and Palliative Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan 2 grid.410813.f0000 0004 1764 6940Department of Gastroenterological Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470 Japan 3 grid.410813.f0000 0004 1764 6940Okinaka Memorial Institute for Medical Research, Tokyo, Japan 4 grid.410786.c0000 0000 9206 2938Department of Health Science School of Allied Health Sciences, Kitasato University, Tokyo, Japan 9 12 2020 9 12 2020 2020 18 32615 8 2020 23 11 2020 © The Author(s) 2020Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Background Esophageal cancer patients often feel depressed and are fearful of metastasis and death. The objective of this study was to clarify the characteristics of patients with psychological distress at all 5 time points compared with patients with no psychological distress especially from standpoints of personal coping styles and QOL. Methods In total, 102 of 152 consecutive patients who attended the outpatient clinic at Toranomon Hospital between April 2017 and April 2019 met eligibility criteria for inclusion in this study. Questionnaires designed to identify psychological distress (HADS-scores) and assess QOL (EORTC QLQ C-30/OES18) were administered at 5 time points from the time of the first outpatient consultation to 3 months after esophagectomy. The questionnaire of coping strategies (MAC-scales) was administered at only time 1 point. Results Based on the trends of HADS-scores, we defined two groups: “persistent high-HAD scores” and “persistent low-HADS scores.” There are strong relationships between psychological distress and coping strategy, and psychological distress and QOL. The possibility that there are relationships between stress coping strategies and some QOL status depending on some point of treatment. Conclusions The psychological distress during the treatment course of esophageal cancer is significantly associated with the coping strategies and QOL influenced by esophagectomy. This study can provide baseline information for identifying patients in need of psychological management and paves the way for larger clinical studies in the future. Keywords Predictive factorsPsychological distressCopingHealth-related quality of lifeEsophageal cancerissue-copyright-statement© The Author(s) 2020 ==== Body Introduction Esophagectomy is the mainstay of curative treatment for esophageal cancer. However, it is a highly invasive surgery with serious postoperative complications and is one of the most complex interventions in gastrointestinal surgery. Recent advances in surgical techniques and perioperative intensive care have reduced the mortality and complications associated with esophagectomy [1], but it continues to be a challenging procedure with a reported mortality rate of 2.9–3.0% and a postoperative complication rate of 42.8–50.0% [2–4]. To meet the increasing demands of healthcare, environmental safety, and food quality, various methods and techniques have been reported as reviewers’ comments. Among these, not only the diagnosis and treatment of cancer but also the mental health of the patient itself is considered to be very important factors. Previous cross-sectional studies addressing emotional outcomes after resection for esophageal cancer have suggested that in 1-year survivors, 64% felt depressed and 80% expressed fear of death and metastasis [5]. These feelings may lead to discontinuation of additional chemotherapy or chemo-radiotherapy after surgery. Moreover, a recent study identified a link between psychological state of anxiety or depression and an increased risk of death from cancer [6, 7]. We described the relationship between psychological distress and health-related quality of life (HRQOL) on each point of the treatment of esophageal cancer in the past report [8]. In this past study, we analyzed risk factors of psychological distress “on each point of the treatment”. However, when we pay attention to the chronological change of the Hospital Anxiety and Depression Scale (HADS) scores of each patient, it revealed that each patient had various mental agitation on each point and presented changes of HADS scores. The perioperative psychological stresses are usually influenced by postoperative course, physical conditions, and surrounding environment. Among these study subjects, two groups without change of the HADS scores exist during all points of the treatment. In other words, there are two types of patients who always feel stress and who always don’t feel stress during the perioperative period [9]. This fact may suggest that these two patients groups (persistent high group and persistent low group) compared with other groups may have different coping styles and that it would be of great help to select these types of patients before starting treatment for the selection of candidates of efficient intervention. Therefore, we extracted these two groups in the present study as “persistent high (H-) group” and “persistent low (L-) group” and further adding the Mental Adjustment to Cancer scale (MAC) to our previously reported scores. If the characteristics of these two patient groups could be predicted, it would be possible to develop appropriate supportive interventions and reduce the psychological stress associated with esophageal cancer. The aim of this study was to clarify the patient characteristics presenting with psychological distress after esophagectomy compared with those without significant psychological distress at all 5 time points especially from the standpoints of personal coping styles and HRQOL. Methods Definition of psychological distress The definition of psychological distress is a negative emotional state characterized by physical and/or emotional discomfort, pain, or anguish. In other words, it is psychological discomfort that interferes with your activities of daily living. The definition of “psychological distress” and the definition of “anxiety and depression” are not the same concepts. However, psychological distress can result in negative views of the environment, others, and the self. Sadness, anxiety, distraction, and symptoms of mental illness are manifestations of psychological distress [10, 11]. Several screening scales have been developed for the early detection of patients’ psychological distress. The HADS score was developed by Zigmond and Snaith [12] and is well accepted to screen for psychiatric problems in medically ill patients. Generally, cancer patients whose psychological distress is mainly characterized by anxiety and depression can benefit from using HADS to detect this distress. And also, Kugaya et al. [9] proved the reliability and validity of the Japanese version of HADS, and the scale appeared to be simple, sensitive, and specific for screening for psychological distress in Japanese cancer patients. Therefore, we use HADS for screening for psychological distress in the present study. Study design and endpoints Participants comprised 152 consecutive patients who attended the outpatient clinic at the Department of Gastrointestinal Surgery at Toranomon Hospital between April 2017 and April 2019 were assessed for trial eligibility. Among these 152 patients, 102 patients who met the eligibility criteria participated in this study. The inclusion criteria were as follows: esophageal cancer including Siewert type I/II tumors of the esophagogastric junction; scheduled for subtotal esophagectomy; age 20 to 85 years; performance status 0 to 2; ability to provide informed consent; with previous oncological therapies for cancer; with previous surgical treatment for other diseases. We included patients 20–85 years old. The reason is because patients may have senile dementia. Generally, about 3% of people between the ages of 65–74 have dementia, 19% between 75 and 84, and nearly half of those over 85 years of age [13]. Therefore, we selected the patients 20–85 years old. The following exclusion criteria were applied: informed consent has not been obtained; on treatment for mental disorder; unsuitability for participation in the study because of psychological or physical stress in the opinion of the medical staff; refusal to undergo surgery; and requested nonsurgical treatment. The flow diagram of this study is shown in Fig. 1. Questionnaires were administered at 5 time points as follows: at the time of outpatient consultation before definitive diagnosis (time 1); at the time of determination of clinical stage before treatment; both of surgery and neoadjuvant therapy (time 2); about 2 weeks after surgery before final staging (time 3); at the time of determination of final staging (time 4); and at 3 months after surgery (time 5). The questionnaires were administered in a fixed waiting room at our institution because we would like to perform the survey acquisition under the stable condition as much as possible. We selected three questionnaires; the Japanese version of HADS, the MAC scale, and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30/the oesophageal cancer-specific module (EORTC QLQ-C30/OES18). The questionnaires (HADS/EORTC QLQ-C30/OES18) were administered at all 5 time points, and the MAC scale was administered once, at time 1. From the trends of HADS scores on each point of the treatment, we selected two groups: “persistent high HADS scores” and “persistent low HADS scores”. Of 102 patients who met the eligibility criteria and participated in this study, 21 patients were allocated to the “persistent high (H-) group,” and 38 patients were allocated to the “persistent low (L-) group” (Fig. 2). We investigated the characteristics of the H-group compared with the L-group especially from standpoints of personal coping styles and HRQOL. Esophageal cancer staging (clinical (c-)/pathological(p-) stage) is defined by the UICC TNM grading system, 7th edition; the sub-classifications based on the depth of invasion of the primary tumor (c-/p-T factors), lymph node involvement (c-/p-N factors), and extent of metastatic disease (c-/p-M factors) [14]. T factors classified the following; Tis: high-grade dysplasia, T1: invasion into the lamina propria, muscularis mucosae, or submucosa, T2: invasion into the muscularis propria, T3: invasion into the adventitia, T4a: invades resectable adjacent structures (pleura, pericardium, diaphragm), and T4b: invades unresectable adjacent structures (aorta, vertebral body, trachea). Similarly, N factors classified the following: N0: no regional lymph node metastases, N1: 1 to 2 positive regional lymph nodes, N2: 3 to 6 positive regional lymph nodes, and N3: 7 or more positive regional lymph nodes. M factors classified the following: M0: no distant metastases and M1: distant metastases [14]. All postoperative complications were graded using the Clavien-Dindo classification [15]; events more severe than grade ≥ III were recorded as complications. We chose this cut-off value on the basis of the Japanese version of HADS, which has been validated for Japanese patients with cancer [12]; a cut-off HADS total score ≥ 11 has been recommended for identifying patients with potential adjustment disorder and major depression [12]. We defined a total score ≥ 11 as indicating psychological distress. The study protocol was approved by the institutional review boards of the Graduate School of Medical and Dental Sciences (approval number M2016-241) and Toranomon Hospital (approval number 1312) and registered with the UMIN Clinical Trials Registry (UMIN-CTR, R000033229). All procedures were conducted in accordance with the ethical standards of the Helsinki Declaration of 1975. Informed consent was obtained from all study participants at the time of the first outpatient appointment. Fig. 1 Flow of patients through the study. Time 1, before definitive diagnosis; time 2, after determination of clinical stage; time 3, postoperatively before final staging; time 4, determination of final stage at 1 month after esophagectomy; time 5, 3 months after esophagectomy Fig. 2 The trend of the HADS scores at time 1 to time 5. Twenty-one patients were allocated to the “persistent high (H-) group,” and 38 patients were allocated to the “persistent low (L-) group” Measures Mental adjustment to cancer scale This scale (MAC scale) assesses the extent to which patients respond and adjust to their diagnosis of cancer and its treatment [16, 17]. It was developed as a self-rating questionnaire that would be patient-friendly and could be administered easily at busy oncology clinics. The scale includes five subscales that measure five types of response: fighting spirit (“I firmly believe that I will get better,” 16 items); helpless/hopelessness (‘I feel that life is hopeless,” 6 items); anxious preoccupation (“I suffer great anxiety about it,” 9 items); fatalism (“I’ve left it all to my doctors”, 8 items); and avoidance (“I don’t really believe I have cancer,” 1 item). Each item is scored on a 4-point Likert scale (1, “definitely does not apply to me”; 4, “definitely applies to me”). Scores for the subscales are calculated by summing the answers for the assigned items. Generally, the coping skills do not greatly change in the short time; therefore, we did not measure the MAC scale at each time point [18, 19]. This questionnaire was administered once, at time 1, in this study. Hospital Anxiety and Depression Scale This scale (HADS) is a 14-item self-report questionnaire comprising of two subscales measuring symptoms of depression (HADS-D) and symptoms of anxiety (HADS-A) over the last week. Each subscale contains 7 items with scores ranging from 0 to 21 [11]. A total score of ≥ 11 on either subscale indicates a definitive case. The Japanese version of HADS was back-translated by Kitamura [20] and its reliability and validity were confirmed by Kugaya et al. [9]. The questionnaire was administered at all 5 time points in this study. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 This questionnaire (EORTC QLQ-C30) is one of the most frequently used questionnaires to measure health-related quality of life in patients with cancer [21–23]. Its 30 question items have been validated in several studies in various types of cancer. This score is a 30-item questionnaire divided into five functional scales (physical, role, cognitive, emotional, and social), three symptom scales (fatigue, pain, and nausea/vomiting), six single-item questions (financial impact and various physical symptoms such as dyspnea, insomnia, anorexia, constipation, and diarrhea), and a global health status/quality of life. The items on the functional subscales are rated on a 4-point Likert scale (1, “not at all”; 4, “very much”). The raw subscale scores are transformed into a scale of 0–100 (0, poor QOL; 100, excellent QOL). The questionnaire was administered at all 5 time points in this study. EORTC QLQ-OES18 questionnaire The EORTC QLQ-OES18 is a self-reported 18-item questionnaire designed to assess health-related quality of life in patients undergoing a single treatment or a combination of treatments for esophageal cancer (i.e., esophagectomy, chemotherapy, radiotherapy, and/or chemo-radiotherapy). It includes 12 items grouped into 4 symptom scales (dysphagia; 3 items, eating; 4 items, reflux; 2 items, and pain; 3 items) and 6 single items (trouble with swallowing saliva, choking, dry mouth, taste, cough, and speech). The time frame is “during the past week.” All items are scored using a 4-point Likert scale (1, “not at all”; 4, “very much”) and responses to the questionnaires were transformed into a 0–100 scale using EORTC guidelines [24]. The questionnaire was administered at all 5 time points in this study. Operative procedure for esophagectomy We perform esophagectomy with two-field or three-field lymphadenectomy depending on the degree of disease progression and the surgical risk involved. The operative thoracic approach entails video-assisted thoracoscopic surgery or thoracotomy and the abdominal approach involves hand-assisted laparoscopic surgery or open laparotomy depending on the individual case. We generally preserve the thoracic duct in patients with clinical stage I disease but resect it in those with clinical stage ≥ II disease for the purpose of lymphadenectomy [13]. However, we resected the thoracic duct even if the patient has clinical stage I disease when we suspect lymph node metastasis or have confirmed a metastasis in the lymph nodes along the bilateral recurrent laryngeal nerves on intraoperative pathologic analysis. However, we try to preserve the thoracic duct in patients at high risk of impaired hepatic or pulmonary function. A manually sutured esophagogastric or esophagoileal anastomosis in the neck is fashioned for all patients [25–29]. Statistical analysis Differences between the two groups (H-group/ L-group) were tested for statistical significance using Fisher’s exact test, the unpaired Student’s t test, the Mann-Whitney U test, and Pearson’s chi-squared test as appropriate. Risk factors for psychological distress (H-group) were assessed by bivariate logistic regression analysis (Backward stepwise selection). The variables with a p value less than 0.05 in univariate analysis were entered into bivariate logistic analysis. Odds ratios (ORs) and their 95% confidence intervals (CIs) were calculated. A p value less than 0.05 was considered statistically significant in bivariate logistic analysis. The correlations between the MAC scale and HRQOL status were assessed using Spearman’s correlation coefficient and statistical significance was tested using Spearman’s rank-sum test. The internal consistency (reliability) of each scale was estimated by Cronbach's alpha coeffcient [30]. A value of 0.70 or greater was considered acceptable for group comparison. All analysis was performed using SPSS for Windows software (version 19.0 J; IBM Corp., Armonk, NY). Results Patient characteristics Fifty of the 152 patents considered for participation in the study were excluded because they had incomplete data (n = 27), declined to participate (n = 11), did not undergo esophagectomy (n = 11), or were receiving treatment for a psychiatric disorder (n = 1), leaving 102 patients for inclusion in the study. From the trends of HADS scores on each point of the treatment of esophageal cancer (Fig. 2), we selected two groups: “persistent high HADS scores” and “persistent low HADS scores”. The characteristics of these patients in the two groups are shown in Table 1. Table 1 Patient demographics and clinical characteristics Variables Persistent low group (N = 38) Persistent high group (N = 21) Others (N = 43) p value Age, years, mean ± SD 64.5 ± 8.079 65.5 ± 6.875 69.2 ± 9.398 0.680 Male sex, % 86.8 85.7 81.4 0.904 BMI, kg/m2, median 22.7 (17.4–27.7) 20.1 (14.1–41.9) 22.0 (15.0–32.1) 0.024 History of cancer 0.243  Yes 6 6 12  No 32 15 31 History of surgery 0.193  Yes 10 9 17  No 28 12 26 History of alcohol consumption 0.353  Yes 34 18 39  No 4 3 4 History of smoking 0.953  Yes 31 17 39  No 7 4 4 Brinkman index 632 (0–2700) 600 (0–2760) 741 (0–3040) 0.975  < 600 0.544  ≥ 600 15 10 19 23 11 24 Thoracic approach 0.234  VATS 35 17 36  Open 1 3 5  None: transhiatal 2 1 2 Abdominal approach 0.022  HALS 13 11 23  Open 6 7 11  Laparoscopic 19 3 9 Lymphadenectomy 0.247  D0 1 2 1  D2/3 37 (11/26) 19 (5/14) 42 (13/29) Curability 0.665  R0 37 20 39  R1/2 1 1 4 Reconstruction 0.780  Gastric tube 25 12 29  Ileocolic 8 6 12  Other 5 3 2 Thoracic duct 0.012  Resected 16 16 30  Preserved 22 5 13 Reconstruction route 0.258  Retrosternal 30 19 39  Posterior mediastinal 8 2 4 Preoperative treatment 0.160  Yes 16 5 27  No 22 16 16 Operation time (min) 592 (350–734) 597 (415–703) 574 (213–774) 0.795 Blood loss (mL) 130 (25–1175) 274 (25–1378) 260 (38–1094) 0.067 G3 postoperative complications 0.855  Yes 8 4 11  No 30 17 32 cT factor (7th) 0.303  1a/1b 2/16 1/5 2/10  2 12 6 7  3 6 6 18  4a/4b 0/2 2/1 2/4 cN factor (7th)  0 25 7 13 0.029  1 10 11 15  2 3 1 15  3 0 2 0 cStage (7th) 0.109  I (IA, IB) 12/9 5/0 10/2  II (IIA, IIB) 3/7 1/7 1/5  III (IIIA, IIIB, IIIC) 3/1/1 1/1/4 9/7/5  IV 2 2 4 p T factor (7th) 0.126  0 2 2 2  1a/1b 5/19 1/6 3/8  2 8 3 9  3 2 6 19  4a/4b 1/1 2/1 2/0 p N factor (7th) 0.276  0 26 10 13  1 8 8 12  2 3 1 11  3 1 2 7 p Stage (7th) 0.062  0 2 1 0  I (IA, IB) 18/2 6/0 8/3  II (IIA, IIB) 2/8 0/3 1/5  III (IIIA, IIIB, IIIC) 4/0/1 3/1/5 12/7/5  IV 1 2 2 Location of tumor 0.510  Cervical Esophagus 2 1 1  Upper thoracic esophagus 5 4 10  Middle thoracic esophagus 15 12 19  Lower thoracic esophagus 7 3 10  Abdominal esophagus 1 0 0  Esophagogastric junction 8 1 3 MAC scale  Fighting spirit 51.0 (34–59) 44.0 (27–57) 48.0 (29–60) 0.001  Helpless/hopeless 7.0 (6–16) 12.0 (6–24) 10.0 (6–16) < 0.001  Anxious preoccupation 21.0 (13–29) 25.0 (17–31) 23.0 (14–32) < 0.001  Fatalism 18.0 (8–29) 21 (12–30) 22.0 (13–28) 0.008  Avoidance 1.0 (1–4) 1.0 (1–4) 2.0 (1–4) 0.793 Abbreviations: SD, standard deviation; BMI, body mass index; EORTC, European Organization for Research and Treatment; HADS, Hospital Anxiety and Depression Scale; VATS, video-assisted thoracoscopic surgery; HALS, hand-assisted laparoscopic surgery; MAC, mental adjustment to cancer; VATS, video-assisted thoracoscopic surgery The mean age of L-group/H-group was 65.3/67.0 years, 86.8%/85.7% were male, and median body mass index was 22.7/20.1, respectively. Univariate analysis between the two groups showed a significant difference in the abdominal approach (p = 0.022), resection or preservation of the thoracic duct (p = 0.012), clinical N factors (p = 0.029), and MAC scales (fighting spirits; p = 0.001, helpless/hopeless; p < 0.001, anxious preoccupation; p < 0.001, and fatalism; p = 0.008). EORTC QLQ C-30 and psychological distress The trend of the scores of EORTC QLQ C-30 on each 5 points of the treatment of esophageal cancer is recorded in Fig. 3 and Table 2; data were compared between the two groups (H-group/L-group). Figure 3 a shows five functional subscales such as physical functioning, role functioning, emotional functioning, cognitive functioning, social functioning, and global health status/quality of life. In almost all the functional subscales on each 5 points, the H-group had a significantly lower and unhealthier level of functioning than the L-group. Figure 3 b shows 9 symptom scales such as fatigue, pain, nausea/ vomiting, pain, dyspnea, insomnia, anorexia, constipation, diarrhea, and financial impact. In almost all the symptom scales on each 5 points, the H-group had a significantly higher level of symptomatology or problems than the L-group. Fig. 3 The trend of the score of EORTC QLQ C-30. a Functioning scales: physical functioning, role functioning, emotional functioning, cognitive functioning, social functioning, and global health status/quality of life. b Symptom scales: fatigue, pain, nausea/vomiting, pain, dyspnea, insomnia, anorexia, constipation, diarrhea, and financial impact Table 2 The details of the QOL status: EORTC QLQ C-30 and EORTC OES-18 Time 1 Time 2 Time 3 Time 4 Time 5 H L P H L P H L P H L P H L P QLQ C-30 Physical 90.3 97.6 0.001 87.5 97.2 0.001 67.6 91.3 < 0.001 67.6 90.0 < 0.001 76.7 95.2 < 0.001 Role 84.6 95.0 0.017 75.8 88.9 0.011 47.6 87.7 < 0.001 43.3 86.7 < 0.001 58.3 92.8 < 0.001 Emotional 63.9 90.6 < 0.001 64.3 92.0 < 0.001 62.5 96.0 < 0.001 65.3 95.7 < 0.001 64.3 97.9 < 0.001 Cognitive 73.6 93.8 < 0.001 74.4 93.4 < 0.001 57.8 94.1 < 0.001 59.1 91.7 < 0.001 66.7 92.8 < 0.001 Social 66.7 90.0 0.001 70.0 82.5 0.045 56.9 88.5 < 0.001 42.6 92.6 < 0.001 56.7 94.8 < 0.001 Global health 41.7 80.1 < 0.001 50.0 76.8 0.002 35.7 72.7 < 0.001 39.8 67.7 < 0.001 40.5 78.3 < 0.001 Fatigue 33.3 14.2 0.001 33.3 14.2 < 0.001 44.4 26.9 < 0.001 55.6 31.0 < 0.001 57.4 24.7 < 0.001 Nausea 8.8 2.4 0.014 9.4 1.9 0.006 7.4 2.4 0.040 13.9 6.5 0.132 20.8 4.9 0.005 Pain 16.7 3.8 0.003 11.9 3.4 0.017 40.9 16.7 < 0.001 29.5 6.8 < 0.001 27.1 3.1 < 0.001 Dyspnea 15.9 9.9 0.187 13.3 9.3 0.383 38.1 17.2 0.003 42.2 22.6 0.017 48.5 17.2 < 0.001 Insomnia 20.4 12.0 0.182 24.1 12.0 0.034 51.9 24.0 0.001 37.0 14.0 < 0.001 25.6 6.7 0.002 Appetite loss 25.5 7.4 0.002 25.0 7.6 0.003 43.7 13.5 0.001 52.4 20.2 0.001 43.3 23.5 0.032 Constipation 14.0 6.9 0.149 20.4 11.5 0.140 18.5 11.1 0.212 7.0 10.8 0.418 16.7 6.5 0.047 Diarrhea 14.0 7.9 0.182 17.5 7.4 0.031 41.2 33.3 0.389 45.2 22.6 0.015 43.6 17.3 0.002 Financial 48.3 13.0 < 0.001 41.2 13.3 < 0.001 40.5 12.5 0.001 44.4 7.3 < 0.001 30.3 8.9 0.003 OES 18 Dysphagia 63.5 94.8 0.003 82.2 96.1 0.002 62.5 92.6 < 0.001 64.4 84.8 < 0.001 63.5 89.9 0.328 Eating 58.3 93.5 < 0.001 68.3 94.3 0.001 59.3 83.9 < 0.001 41.7 74.3 < 0.001 47.2 78.8 0.010 Reflux 87.5 96.2 0.004 87.8 96.2 0.010 86.1 94.6 0.040 81.7 90.0 0.122 75.9 91.0 0.161 Eso. pain 82.7 98.0 < 0.001 87.5 97.4 0.005 71.4 93.8 0.001 75.9 94.0 0.005 74.1 97.5 0.010 Saliva 90.0 97.4 0.033 90.5 100 0.026 80.4 95.4 0.002 74.5 91.7 0.002 91.1 96.8 0.442 Choking 86.7 96.5 0.011 88.3 97.4 0.012 74.5 90.7 0.003 70.6 88.9 0.001 73.8 89.2 0.105 Dry mouth 70.8 88.0 0.009 70.8 85.2 0.031 58.8 79.3 0.007 57.1 86.0 0.002 69.7 92.5 0.442 Taste 87.0 95.4 0.073 76.2 91.7 0.050 66.7 88.6 < 0.001 61.5 89.6 0.001 69.4 89.7 0.161 Cough 90.0 94.6 0.249 86.0 94.6 0.053 64.1 78.1 0.092 53.3 79.0 0.009 60.6 85.1 0.721 Speech 91.7 94.4 0.469 95.0 94.4 0.899 62.2 81.2 0.010 47.6 72.6 0.004 56.7 92.2 0.721 EORTC QLQ OES-18 and psychological distress The trend of the scores of EORTC QLQ OES-18 on each 5 points is recorded in Fig. 4 and Table 2; data were compared between the two groups (H-group/L-group). Figure 4 a and b show four symptom scales such as dysphagia, eating restriction, reflux, esophageal pain, and 6 single items such as trouble with swallowing saliva, choking, dry mouth, taste, cough, and speech. In almost all these scales on each 5 points, the H-group had a significantly higher level of symptomatology or problems than the L-group. Fig. 4 The trend of the score of EORTC QLQ OES18. a Symptom scales: dysphagia, eating restriction, reflux, esophageal pain. b Single items: trouble with swallowing saliva, choking, dry mouth, taste, cough, and speech The relations between the stress coping strategies and QOL status There were correlations between the MAC scale and QOL status in some scales. The relationship between two variables is generally considered moderate when their correlation coefficient (r) value is larger than 0.5 and also considered strong correlation when their r value is larger than 0.7 [31]. The internal consistency (reliability) of each scale was estimated by Cronbach’s alpha coefficient. A value of 0.70 or greater was considered acceptable for group comparison [30]. In this study, the r values and Cronbach’s alpha coefficient between the MAC scale (helpless/hopeless) and some variables of EORTC QLQ C-30/OES18 in several points of perioperative treatment were global (time 3; r = − 0.521 (α = 0.501); p < 0.001/time 5; r = − 0.576 (α = 0.558) ; p < 0.001), physical (time 5; r = − 0.628 (α = 0.614) ; p < 0.001), emotional (time 1; r = − 0.520 (α = 0.537) ; p < 0.001/time 3; r = − 0.559 (α = 0.560) ; p < 0.001), cognitive (time 3; r = − 0.558 (α = 0.533) ; p < 0.001/time 4; r = − 0.524 (α = 0.522) ; p < 0.001), social (time 5; r = − 0.542 (α = 0.692) ; p < 0.001), fatigue (time 2; r = 0.530 (α = 0.533) ; p < 0.001/time 5; r = 0.583 (α = 0.562) ; p < 0.001), financial difficulty (time 4; r = 0.509 (α = 0.516) ; p < 0.001), OES18: eating restriction (time 3; r = − 0.518 (α = 0.516) ; p < 0.001/ time 4; r = − 0.501 (α = 0.733) ; p = 0.001/ time 5; r = − 0.573 (α = 0.589) ; p < 0.001), and speech (time 5; r = 0.503 (α = 0.770) ; p = 0.001). Among these variables, there were moderate correlations between helpless/hopeless and eating restriction scale at time 4/ speech scale at time 5 considering Cronbach's alpha coefficient. On the other hand, there was a strong correlation between helpless/hopeless and role functioning scale at time 5 (r = − 0.752 (α = 0.752); p < 0.001). Discussion In this study, we evaluated psychological distress, stress coping strategy, and quality of life in patients with esophageal cancer from the time of the outpatient consultation (time 1) through to 3 months after esophagectomy (time 5). Our results showed that there are strong relationships between psychological distress and stress coping strategy, and psychological distress and quality of life. And also, this study suggests that there are relationships between stress coping strategies and some HRQOL status depending on the point of treatment. We discussed and described that the clinical factors associated with psychological distress, focusing on the influence of HRQOL and the coping strategies of all patients with esophageal cancer on each point of the treatment [8]. In our past study, we analyzed risk factors of psychological distress “on each point of the treatment.” However, when we pay attention to the chronological change of HADS scores of each patient, it revealed that each patient had various mental agitation on each point and presented changes of HADS scores, for example, 21 patients had “persistent high HADS scores”, 38 patients had “persistent low HADS”, 12 patinets had “High-Low”, 11 patients had “Low-High”, 15 patients had “Low-High-Low”, and so on [8]. In the previous cross-sectional studies, the emotional outcomes after resection for esophageal cancer have suggested that in 1-year survivors, 64 % felt depressed, and 80% expressed fear of death and metastasis [5]. Our present research revealed that about 60–70% of patients with esophageal cancer on each point of the treatment had psychological distress like the past report. However, only about 20% of patients had psychological distress at all times (persistent high HADS scores) during the treatment. Among these study subjects, two groups without change of the HADS scores exist during each point of the treatment. The possibility that these two patients group (persistent high group and persistent low group) compared with other groups may have a different coping style was guessed. Therefore, we extracted these two groups in the present study as “persistent high (H-) group” and “persistent low (L-) group” and further adding the coping skills questionnaire (MAC scale) to our previously reported scores. Patients background In the H-group, there was a tendency for many cases to be resected with thoracic duct and to be positive for lymph node metastases. We generally resect the thoracic duct in patients with clinical stage ≥ II advanced disease for the purpose of lymphadenectomy. One possible explanation for these results is that the degree of disease progression may affect perioperative psychological distress. Coping skills In the past reports, the possibility that the coping skill improves the psychological distress had been discussed because there were significant associations between the coping skills and psychological distress [16, 17, 32]. However, it is still unclear whether the coping skills act on the psychological distress effectively in the various situations of the episode of the esophageal cancer treatment. In the present study, patients with a helpless/hopeless response, anxious preoccupation, and fatalism were at increased risk of psychological distress, whereas those with a fighting spirit response were better able to adjust to their situations. And also, the results showed that the most beneficial response is fighting spirit and the most deleterious response may be helpless/hopeless. If we can grasp the stress coping-style of the patients with esophageal cancer even one investigation before treatment, it would be possible to develop appropriate supportive interventions and reduce the psychological stress, anxiety, and depressive feelings associated with esophageal cancer and surgery. HRQOL: EORTC QLQ C-30/OES18 The emotional aspects such as worry and irritability have been shown to be associated with HRQOL [33]. And also, in the past reports, there was a significant association between the HRQOL and psychological distress [34–36]. We similarly described the psychological distress during the treatment course of esophageal cancer is significantly associated with HRQOL influenced by esophagectomy [8]. In the present study, although we selected only two groups of patients with or without psychological distress at all times for the perioperative period, we were able to describe that patients with psychological distress at all times had a significantly lower and unhealthier level of functioning in almost all the functional scales, and a higher level of symptomatology or problems in almost all the symptom scales than the patients without psychological distress. The symptoms that patients with esophageal cancer have would be affected physically by esophageal cancer itself such as “Fatigue,” “Nausea/vomiting,” “Pain,” and “Appetite loss” in EORTC QLQ C-30 and “Dysphagea,” “Eating restriction,” “Reflux,” and “Esophageal pain” in OES 18 especially at time 1/time 2 (preoperation). And also, the symptoms that patients after esophagectomy have would be affected physically by surgery itself such as “Fatigue,” “Nausea/vomiting,” “Pain,” “Dyspnea,” “Insomnia,” and “Appetite loss” in EORTC QLQ C-30 and “Dysphagea,” “Eating restriction,” “Reflux,” “Esophageal pain,” “Choking,” “Dry mouth,” “Taste,” “Cough,” and “Speech” in OES 18 especially at time 3/time 4 (postoperation). Through all episodes of treatment, “The financial difficulties status,” “Role functioning,” and “Social status” was a significant factor for psychological distress. We could guess that the patients have large anxiety about treatment strategies and costs of esophageal cancer treatments particularly in the era of multimodal treatment which requires more time and cost. Also, patients feel so sorry to trouble his or her family because of their physical problems such as “eating difficulties.” Except for our past [8] and present reports, there is no report which described more detail about the association between HADS and HRQOL. The relations between coping skills and HRQOL It is usually expected that patients with advanced diseases have a tendency of higher HADS scores and more impaired QOL. It is also suggested that those who were informed of very advanced or non-curable disease status revealed surgically or pathologically would have higher HADS scores and more impaired QOL after the information. Psychological distress, QOL, disease status, and its recognition by the patient, all these factors should correlate with each other and their causal relationships are complicated and can vary with time course. Patients included neither in H-group nor in L-group, who showed chronological changes of HADS score levels, might have been influenced by the information provided through the treatment course. Further examination will be necessary about these strategies in the future. However, this study showed that more than 50% of the patients consistently had high or low HADS scores throughout the course of the treatment of their esophageal cancers, and surprisingly, there was little difference in clinical characteristics between the two groups, but the two groups had a clear difference in 4 out of 5 subscales of the MAC scale measured preoperatively. Therefore, at least for such half or more patients, preoperative MAC scale evaluation can be useful in selecting patients who can benefit by appropriate supportive interventions on their coping skills and it may reduce their psychological distress and hopefully improve their QOL. There is no report which described the association between the MAC scale and HRQOL in the past. Therefore, it is still unclear whether the Coping skills act on the HRQOL effectively in the various situations of the episode of the esophageal cancer treatment. We investigated in more detail that the association between stress coping strategy and HRQOL on each point of the treatment of esophageal cancer. As described above, most of the symptoms that patients with esophageal cancer have would be affected physically by esophageal cancer itself and the treatment including an operation. However, there is a possibility that coping skills would be related to the emergence of postoperative symptoms. In fact, there was a correlation between the MAC scale and QOL status in some scales such as helpless/hopeless—eating restriction, speech, and role functioning in the present study. The major limitations for this study are the single-center design and the small sample size investigated. An external validation study involving a sufficient number of patients would be needed to confirm our observations; a multicenter study with a larger number of cases is also warranted. We selected four questionnaires according to the past reports, but using these questionnaires might not be sufficient to fulfill the purpose of our study. There might be other more suitable questionnaires to satisfy this study purpose. There were also several factors potentially associated with psychological distress related to treatment for esophageal cancer that could not be controlled for in this study. Nevertheless, our results confirm that the risk of psychological distress can be estimated reasonably accurately using the clinical factors investigated in this study. Prospective accumulation of clinical data using this study could provide important information for better psychological management of patients undergoing treatment for esophageal cancer. Conclusion This study showed that the psychological distress during the treatment course of esophageal cancer is significantly associated with the coping strategies and HRQOL influenced by esophagectomy. The current results may warrant prospective intervention through enhanced recovery after surgery to better manage patients undergoing highly invasive procedures for esophageal cancer. This study uses basic clinical data and may provide the baseline information for risk stratification for psychological management and for future clinical studies in these patients. Abbreviations HADSHospital Anxiety and Depression Scale MAC scaleMental Adjustment to Cancer scale EORTC QLQ-C30/OES18the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30/the oesophageal cancer-specific module HRQOLHealth-related quality of life Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Authors’ contributions Yu Ohkura, Kanako Ichikura, and Eisuke Matsushima designed the study, wrote the manuscript, revised it critically for important intellectual content, and approved its content; Yu Ohkura, Junichi Shindoh, Kanako Ichikura, Masaki Ueno, Harushi Udagawa and Eisuke Matsushima created the study materials and recruited patients. All authors read and approved the final manuscript. Availability of data and materials Some advocates of clinical data sharing are keen for data to be shared in agreed, standardized formats to facilitate its automated reuse for statistical analysis. Ethics approval and consent to participate The study protocol was approved by the institutional review boards of the Graduate School of Medical and Dental Sciences (approval number M2016-241) and Toranomon Hospital (approval number 1312) and registered with the UMIN Clinical Trials Registry (UMIN-CTR, R000033229). All procedures were conducted in accordance with the ethical standards of the Helsinki Declaration of 1975. Informed consent was obtained from all study participants at the time of the first outpatient appointment. Consent for publication Informed consent was obtained from these patients for publication of this report. Competing interests None declared. ==== Refs References 1. Takeuchi H Saikawa Y Oyama T Ozawa S Suda K Wada N Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy World J Surg. 2010 34 277 284 10.1007/s00268-009-0331-9 20033687 2. Takeuchi H Miyata H Gotoh M Kitagawa Y Baba H Kimura W A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database Ann surg. 2014 260 259 266 10.1097/SLA.0000000000000644 24743609 3. Birat D Brian SD John GH Brett CS John TV James PD Patient and peri-operative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), 2005-2008 J Gastrointest Surg. 2010 14 1492 1501 10.1007/s11605-010-1328-2 20824375 4. Ohkura Y Miyata H Konno H Development of a model predicting the risk of eight major postoperative complications after esophagectomy based on 10826 cases in the Japan National Clinical Database J Surg Oncol. 2020 121 313 321 10.1002/jso.25800 5. Hellstadius Y Lagergren P Lagergren J Aspects of emotional functioning following oesophageal cancer surgery in a population-based cohort study Psycho-Oncology. 2015 24 47 53 10.1002/pon.3583 24895142 6. Batty GD Russ TC Stamatakis E Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies BMJ. 2017 356 j108 10.1136/bmj.j108 28122812 7. Bouras G Markar SR Burns EM Linked hospital and primary care database analysis of the incidence and impact of psychiatric morbidity following gastrointestinal cancer surgery in England Ann Surg. 2016 264 93 99 10.1097/SLA.0000000000001415 26649592 8. Ohkura Y Ichikura K Shindoh J Relationship between psychological distress and health-related quality of life at each point of the treatment of esophageal cancer Esophagus. 2020 17 312 322 10.1007/s10388-019-00710-y 31897762 9. Kugaya A Akechi T Okuyama T Screening for psychological distress in Japanese cancer patients Jpn J Clin Oncol 1998 28 5 333 338 10.1093/jjco/28.5.333 9703862 10. Horwitz AV Distinguishing distress from disorder as psychological outcomes of stressful social arrangments Health. 2007 11 273 289 10.1177/1363459307077541 17606693 11. Ridner SH Psychological distress: concept analysis Journal of Advanced Nursing. 2004 45 5 536 545 10.1046/j.1365-2648.2003.02938.x 15009358 12. Zigmond AS Snaith RP The hospital anxiety and depression scale Acta Psychiatr Scand. 1983 67 361 370 10.1111/j.1600-0447.1983.tb09716.x 6880820 13. Umphred, Darcy. Neurological rehabilitation (6th ed.). 2012: 838. 14. Sobin LH Gospodarowicz MK Wittekind C International Union Against Cancer. Oesophagus including oesophagogastric junction. “TNM classification of malignant tumours” 2009 West Sussex,UK Wiley-Blackwell 66 72 15. Dindo D Demartines N Clavien PA Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 2004 240 205 213 10.1097/01.sla.0000133083.54934.ae 15273542 16. Osborne RH Elsworth GR Kissane DW The Mental Adjustment to Cancer (MAC) Scale: replication and refinement in 632 breast cancer patients Psychological Medicine. 1999 29 1335 1345 10.1017/S0033291799001142 10616939 17. Watson M Greer S Young J Development of a questionnaire measure of adjustment to cancer: the MAC scale Psychological Medicine. 1988 18 203 209 10.1017/S0033291700002026 3363039 18. Aldwin CM Revenson TA Does coping help? A reexamination of the relation between coping and mental health Journal of Personality and Social Psychology. 1987 53 337 348 10.1037/0022-3514.53.2.337 3625471 19. Sandler IN Tein JY Mehta P Coping efficacy and psychological problems children of divorce Child Development. 2000 71 1099 1118 10.1111/1467-8624.00212 11016569 20. Kitamura T. Hospital Anxiety and Depression Scale. Seisinka Sindangaku 1993; 4: 371-372(Japanese). 21. Tabano M Condosta D Coons M Symptoms Affecting quality of life in women with gynaecologic cancer Seminarsin Ontology Nursing 2002 18 3 223 230 10.1053/sonu.2002.34084 22. Fayers PM, Aaronson NK, Bjordal K, et al. The EORTC QLQ C30 scoring manual (3rdEdition). Published by: European Organisation for Research and Treatment of Cancer, Brussels. 2001. 23. Birhanu AA Shiferaw N Lukman Y Reliability and validity of Amharic version of EORTC QLQ-C 30 questionnaire among gynecological cancer patients in Ethiopia PLoS ONE. 2016 11 e0157359 10.1371/journal.pone.0160234 27304066 24. Fujita T Okada N Sato T Translation, validation of the EORTC esophageal cancer quality-of-life questionnaire for Japanese with esophageal squamous cell carcinoma: analysis in thoraco-laparoscopic esophagectomy versus open esophagectomy Japanese Journal of Clinical Oncology. 2016 46 7 615 621 10.1093/jjco/hyw040 27056967 25. Udagawa H Akiyama H Surgical treatment of esophageal cancer: Tokyo experience of the three-field technique Dis Esophagus. 2001 14 110 114 10.1046/j.1442-2050.2001.00166.x 11553219 26. Akiyama H Miyazono H Tsurumaru M Use of the stomach as an esophageal substitute Ann Surg. 1978 188 606 610 10.1097/00000658-197811000-00004 718285 27. Udagawa H Ueno M Kinoshita Y Rationale for video-assisted radical esophagectomy Gen Thorac Cardiovasc Surg. 2009 57 127 131 10.1007/s11748-008-0362-4 19280307 28. Udagawa H Ueno M Shinohara H The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer J Surg Oncol. 2012 106 6 742 747 10.1002/jso.23122 22504922 29. Udagawa H Ueno M Shinohara H Should lymph nodes along the thoracic duct be dissected routinely in radical esophagectomy? Esophagus 2014 11 204 210 10.1007/s10388-014-0433-9 30. Cronbach LJ CoeYcient alpha and the internal structure of tests Psychometrika 1951 16 297 10.1007/BF02310555 31. Nguyen NT, Gaol FL, Hong TP, et al. Intelligent Information and Database Systems: 11th Asian Conference, ACIIDS 2019, Yogyakarta, Indonesia, April 8–11, 2019, Proceedings, Part II. 2019: 110. 32. Akechi T Kugaya A Okamura H Predictive factors for psychological distress in ambulatory lung cancer patients Support Care Cancer. 1998 6 281 286 10.1007/s005200050167 9629883 33. De Boer AG Genovesi PI Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma Br J Surg. 2000 87 1716 1721 10.1046/j.1365-2168.2000.01600.x 11122191 34. Subramaniam S, Kong YC, Chinna K, et al. Health-related quality of life and psychological distress among cancer survivors in a middle-income country. Psycho-oncology. 2018:1–8. 35. Lagergren P Avery KNL Hughes R Health-related Quality of life among patients cured by surgery for esophageal cancer Cancer. 2007 110 686 693 10.1002/cncr.22833 17582628 36. Hulbert-Williams N Neal R Morrison V Anxiety, depression and quality of life after cancer diagnosis: what psychosocial variables best predict how patients adjust? Psycho-Oncology. 2012 21 857 867 10.1002/pon.1980 21695744